口蹄疫ワクチン市場：製品、タイプ、用途、流通チャネル別-2024-2030年の世界予測

口蹄疫ワクチン市場規模は2023年に26億9,000万米ドルと推定され、2024年には29億3,000万米ドルに達し、CAGR 9.10％で2030年には49億5,000万米ドルに達すると予測されます。

口蹄疫ワクチンは、ウシ、ブタ、ヒツジ、ヤギなどの感受性の高い家畜において、口蹄疫ウイルス（FMDV）に対する免疫学的反応を引き起こすように設計された生物製剤です。ワクチンには不活化（死滅）ウイルスまたはウイルスの特定の部分が含まれており、動物の免疫系を刺激して抗体を産生させる。これらの抗体は、動物が生きたウイルスに暴露された場合、そのウイルスを認識し、対抗することができます。FMDの世界の流行と発生率、ワクチン接種の義務化と動物衛生規制に関する政府の方針が、市場の成長を高めています。しかし、新しいワクチンの承認プロセスやウイルス株のばらつきは、万能ワクチンの開発を複雑にしています。とはいえ、ワクチン技術や製造手法の進歩に加え、口蹄疫ワクチンに対する政府の承認が拡大することで、口蹄疫ワクチン市場の成長機会が生まれると期待されています。

製品予期せぬ口蹄疫の侵入に迅速な解決策を提供する緊急用ワクチンの利用が急増

従来の口蹄疫（FMD）用ワクチンには、数十年にわたって使用されてきた不活化ワクチンが含まれます。これらのワクチンは、化学的に不活化されたウイルスで構成されており、病気を引き起こすことはないが、ワクチン接種を受けた動物に免疫反応を引き起こします。従来のワクチンは、FMDが流行している地域や慢性的な疾病リスクのある地域での予防措置として使用されています。ウイルスに継続的に暴露される地域では従来型ワクチンが好まれ、群衆免疫を提供し、広範なアウトブレイクを予防します。これらのワクチンは、定期的なワクチン接種プログラムで、リスクのある集団に投与されます。緊急用ワクチンは、流行に直面した場合や差し迫った脅威が確認された場合に使用されます。迅速に免疫を誘導し、病気の蔓延を食い止めることを目的としています。これらのワクチンは同じ不活化ワクチンであってもよいです。しかし、これらのワクチンは、予期せぬFMDアウトブレイクの影響を最小限に抑えるため、迅速な配備のために用意されています。緊急ワクチンの使用は、特にFMDが通常発生していない地域で、活発なアウトブレイクを抑えるために迅速な対応が必要な場合に望ましいです。このような緊急介入は、経済的損失や無発病地域への感染の拡大を防ぐために非常に重要です。

流通経路：進化する口蹄疫ワクチン流通のための動物病院

動物病院は口蹄疫ワクチンの重要な流通経路です。これらの施設は家畜生産者と密接に連携して家畜の健康を維持し、個別のケアやワクチン接種サービスを提供しています。獣医師は、診療する家畜がFMDから速やかに保護されるよう、迅速な免疫増強が可能なワクチンを好むことが多いです。また、家畜の健康を確保するため、副作用の少ないワクチンを選ぶこともあります。政府機関は口蹄疫（FMD）ワクチンの配布において重要です。これらの機関は主に、疾病の発生を抑制・撲滅するための集団予防接種プログラムに関与しています。これらの機関は、特に口蹄疫のリスクが高い地域において、大規模な購買力と広くワクチンを配布する能力を持っていることが多いです。政府機関は、高い有効性が証明され、より長い期間免疫を付与できるFMDワクチンを好むかもしれないです。

地域別の洞察

アジア太平洋地域は、畜産における経済的損失を防ぐという消費者のニーズに後押しされ、FMDワクチン市場において大きな成長の可能性を示しています。中国やインドを含む各国は、効果的なワクチンを開発するための研究や技術に多額の投資を行っており、ワクチン接種の普及を促すために政府が費用を補助することも多いです。南北南北アメリカ、特に北米を含むFMD非発生地域では、主に緊急時の備えとしてFMDワクチンに投資しています。政府の政策や国際貿易協定は、バイオセキュリティーを目的としたFMD非免疫地域の維持のため、これらの地域での購買行動に影響を与えています。さらに、市場の需要は国家緊急備蓄制度に沿った緊急備蓄が中心となっています。欧州市場は予防対策で成熟している一方、アフリカと中東はアウトブレイクを管理・緩和する必要性に駆られています。欧州の高度なバイオテクノロジー・ソリューションから、アフリカの利用しやすく費用対効果の高いワクチンまで、多様な消費者ニーズがEMEA地域を特徴づけています。さらに、この地域の市場は、次世代ワクチンへの継続的な研究と投資によって先進的なものとなっています。アフリカではFMDが流行しており、効果的なワクチンの必要性が高まっています。FAOやOIEといった国際機関が支援するワクチン接種キャンペーンに依存している国も多く、市場はダイナミックです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、口蹄疫ワクチン市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、口蹄疫ワクチン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.口蹄疫ワクチン市場の市場規模および予測は？

2.口蹄疫ワクチン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.口蹄疫ワクチン市場の技術動向と規制枠組みは？

4.口蹄疫ワクチン市場における主要ベンダーの市場シェアは？

5.口蹄疫ワクチン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で口蹄疫の発生率と発生率が増加
    • 動物の健康を促進する義務的ワクチン接種に関する政府の政策の有無
  • 抑制要因
    • 熱不安定性と短命な免疫に関する懸念
  • 機会
    • 口蹄疫に対する先進的なワクチンを生み出すための研究開発への投資増加
    • 口蹄疫ワクチンの政府承認が増加
  • 課題
    • 野生株との組み換えのリスク
• 市場セグメンテーション分析
  • 製品：病気の予期せぬ侵入に迅速な解決策を提供する緊急ワクチンの利用の急増
  • 流通チャネル：口蹄疫ワクチンの流通のための獣医クリニックの進化
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 口蹄疫ワクチン市場：製品別

• 従来型
• 緊急

第7章 口蹄疫ワクチン市場：タイプ別

• DNAワクチン
• 不活化ワクチン
• 生弱毒化ワクチン
• 生ウイルスベクターワクチン
• ペプチドワクチン

第8章 口蹄疫ワクチン市場：用途別

• 牛
• ヤギ
• 豚
• 羊

第9章 口蹄疫ワクチン市場：流通チャネル別

• 政府機関
• 獣医クリニック

第10章 南北アメリカの口蹄疫ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の口蹄疫ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの口蹄疫ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • インド免疫学社の口蹄疫ワクチンの新施設がハイデラバードのゲノムバレーに建設予定
  • バイオジェネシス・バゴ、口蹄疫との戦いで新たな節目を迎える
  • インドネシア、口蹄疫の全国予防接種を開始
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. FOOT & MOUTH DISEASE VACCINES MARKET DYNAMICS
• FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 59. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 60. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 67. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 68. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 69. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 70. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 71. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 72. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 73. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 74. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 75. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 76. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 77. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 80. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 83. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 84. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 94. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 103. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 106. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 107. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 110. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 111. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 112. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 113. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 114. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 115. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 118. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 119. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 120. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 121. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 126. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 127. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 128. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 129. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 130. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 131. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 134. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 135. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 142. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 143. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 146. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 147. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 150. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 151. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 154. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 155. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 156. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 157. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 158. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 159. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 160. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 161. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 162. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 163. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 164. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 165. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 166. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 174. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 175. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 182. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 183. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 184. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 185. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 186. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 187. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 190. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 191. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 192. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 193. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 198. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 209. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 214. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 215. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 216. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 217. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 224. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 225. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 226. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 227. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 228. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 229. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 232. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 233. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 234. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 235. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 236. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 237. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 240. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 241. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 242. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 243. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 244. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 245. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 248. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 249. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 250. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 251. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 254. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 255. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 256. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 257. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 258. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 259. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 264. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 265. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 266. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 267. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 268. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 269. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 272. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 273. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 274. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 275. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 276. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 277. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 280. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 281. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 282. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 283. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 284. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 285. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 286. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 287. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 288. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 289. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 290. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 291. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 292. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 293. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 294. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 295. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 296. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 297. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 298. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 299. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 300. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 301. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 302. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 303. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 304. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 305. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 306. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 307. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 308. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 309. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 310. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 311. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 312. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 314. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 316. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 318. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET

[199 Pages Report] The Foot & Mouth Disease Vaccines Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030.

Foot and mouth disease vaccines are biologics designed to elicit an immunological response against the foot and mouth disease virus (FMDV) in susceptible livestock, such as cattle, swine, sheep, and goats. The vaccines contain inactivated (killed) viruses or specific parts of the virus, which stimulate the animal's immune system to produce antibodies. These antibodies can recognize and counteract the live virus if the animal is ever exposed to it, thereby preventing or reducing the severity of the disease. The prevalence and incidence of FMD outbreaks across the globe and government policies regarding mandatory vaccinations and animal health regulations increase market growth. However, stringent regulatory approval processes for new vaccines and variability in virus strains complicate the development of a universal vaccine. Nevertheless, advances in vaccine technology and production methodologies coupled with growing government approvals for FMD vaccines are expected to create growth opportunities for the foot and mouth disease vaccine market.

Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease

Conventional vaccines for Foot & Mouth Disease (FMD) encompass inactivated vaccines that have been used for decades. These vaccines are composed of chemically inactivated viruses incapable of causing the disease; however, they evoke an immune response in vaccinated animals. Conventional vaccines are used as a preventive measure in regions where FMD is endemic or with a chronic disease risk. The preference for conventional vaccines is high in areas with continuous exposure to the virus, providing herd immunity and preventing widespread outbreaks. They are administered in regular vaccination programs to populations at risk. Emergency vaccines are used in the face of an outbreak or when an imminent threat is identified. They are designed to induce immunity rapidly and contain the spread of the disease. These vaccines may be of the same inactivated type. However, they are reserved for quick deployment to minimize the impact of unforeseen FMD outbreaks. The application of emergency vaccines is preferred when a rapid response is necessary to control an active outbreak, especially in areas where FMD is not usually present. This immediate intervention is critical to prevent economic losses and the potential spread to disease-free regions.

Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines

Veterinary clinics are significant channels for the distribution of FMD vaccines. These establishments work closely with livestock producers to maintain the health of the animals, offering individualized care and vaccination services. Veterinarians often prefer vaccines that offer rapid immunity build-up to ensure the livestock they treat are promptly protected against FMD. They may opt for vaccines with minimal side effects to ensure the livestock's well-being. Government Institutions are critical in distributing foot and mouth disease (FMD) vaccines. They are mainly involved in mass vaccination programs to control and eradicate disease outbreaks. These institutions often have large-scale purchasing power and the ability to distribute vaccines widely, especially in regions at high risk for FMD. Government bodies may prefer FMD vaccines that are proven to be highly effective and can confer immunity for a longer duration, which is vital for controlling the disease in endemic areas.

Regional Insights

The Asia-Pacific region demonstrates significant growth potential in the FMD vaccine market, driven by consumer needs to prevent economic losses in livestock production. Countries, including China and India, invest heavily in research and technology to develop effective vaccines, with governments often subsidizing costs to encourage widespread vaccination. The Americas, particularly the FMD-free zones, including North America, invest in FMD vaccines primarily for emergency preparedness. Government policy and international trade agreements influence purchasing behavior within these regions to maintain FMD-free status geared towards biosecurity. Furthermore, the market demand is centered on contingency stocks in alignment with the National Emergency Stockpile System. Europe's market is mature with preventative measures, while Africa and the Middle East are driven by the need to manage and mitigate outbreaks. Diverse consumer needs, from advanced biotechnological solutions in Europe to accessible and cost-effective African vaccines, characterize the EMEA region. Furthermore, the market here is advanced with ongoing research and investment in next-generation vaccines. Africa faces endemic FMD challenges, which amplifies the need for effective vaccines. The market is dynamic, with many countries reliant on vaccination campaigns supported by international organizations such as the FAO and OIE.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Foot & Mouth Disease Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Foot & Mouth Disease Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Foot & Mouth Disease Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bharatbiotech International Ltd., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Botswana Vaccine Institute, Brilliant Bio Pharma, Brilliant Bio Pharma Pvt. Ltd., China Animal Husbandry Group, Indian Immunologicals Ltd., Inner Mongolia Biwei Antai Biotechnology Co., Ltd., Inovio Pharmaceuticals, Inc., Jinyu Baoling Biopharmaceutical Co., Ltd., Laboratorios Bago S.A., Limor de Colombia, Merck KGaA, Merial S.A.S., MorphoSys AG, QYH Biotech Co., Ltd., Shenlian Biopharmaceutical (Shanghai) Co., Ltd., Vallee S.A., Vetal Animal Health Products S.A., and Veterinary Serum and Vaccine Research Institute.

Market Segmentation & Coverage

This research report categorizes the Foot & Mouth Disease Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Conventional
  • Emergency

• Type
  • DNA Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Live Viral Vector Vaccines
  • Peptide Vaccines

• Application
  • Cattle
  • Goat
  • Pigs
  • Sheep

• Distribution Channel
  • Government Institutions
  • Veterinary Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Foot & Mouth Disease Vaccines Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Foot & Mouth Disease Vaccines Market?

3. What are the technology trends and regulatory frameworks in the Foot & Mouth Disease Vaccines Market?

4. What is the market share of the leading vendors in the Foot & Mouth Disease Vaccines Market?

5. Which modes and strategic moves are suitable for entering the Foot & Mouth Disease Vaccines Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence and incidence of FMD outbreaks across the globe
    • 5.1.1.2. Availability of government policies for mandatory vaccinations that promote animal health
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns related to thermal instability and short-lived immunity
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D to yield advanced vaccines for FMD
    • 5.1.3.2. Growing government approvals for FMD vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of recombination with the wild strains
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease
  • 5.2.2. Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Foot & Mouth Disease Vaccines Market, by Product

• 6.1. Introduction
• 6.2. Conventional
• 6.3. Emergency

7. Foot & Mouth Disease Vaccines Market, by Type

• 7.1. Introduction
• 7.2. DNA Vaccines
• 7.3. Inactivated Vaccines
• 7.4. Live Attenuated Vaccines
• 7.5. Live Viral Vector Vaccines
• 7.6. Peptide Vaccines

8. Foot & Mouth Disease Vaccines Market, by Application

• 8.1. Introduction
• 8.2. Cattle
• 8.3. Goat
• 8.4. Pigs
• 8.5. Sheep

9. Foot & Mouth Disease Vaccines Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Government Institutions
• 9.3. Veterinary Clinics

10. Americas Foot & Mouth Disease Vaccines Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Foot & Mouth Disease Vaccines Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Indian Immunologicals' new facility for FMD vaccines to come up in Hyderabad's Genome Valley
  • 13.3.2. Biogenesis Bago reaches a new milestone in its fight against Foot and Mouth Disease
  • 13.3.3. Indonesia launching nationwide vaccinations for foot and mouth disease
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio